Treatment of headaches Flashcards
Biological effects of Brady kinin and Kallidin
autocoids that induce inflammation, pain and vasodilation
Synthesis of kinins
- Kininogens → Kallikrein → Kinins
- Kininogens are precursors of kinins
- Kallikreins are serine proteases that cleave Kininogens into kinins
- High Molecular Weight Kininogen (HMWK) is cleaved by Plasma
Kallikrein into bradykinin - Low Molecular Weight Kininogen (LMWK) is cleaved by Tissue Kallikrein
into kallidin which is then cleaved by an Aminopeptidase into Bradykinin
The plasma kinin forming system
- Autoactivation of factor XII (Hageman Factor) to factor XIIa. Factor XIIa
converts Plasma Prekallikrein to Plasma Kallikrein, Plasma Kallikrein
converts High Molecular Weight Kininogen (HMWK) to Bradykinin. Plasma
Kallikrein activates factor XIIa. This is a positive feedback loop, and the first
step in the intrinsic clotting cascade that enhances Bradykinin synthesis.
The tissue kallikrien-kinin forming system
- Tissue Kallikrein is different than Plasma Kallikrein.
- Tissue Kallikrein converts Low Molecule Weight Kininogen (LMWK) to
Kallidin. Aminopeptidase converts Kallidin to Bradykinin
Metabolism of Kinins
1.Carboxypeptidase N and M (CPN, CPM) (Also known as Kininase I) are
metallopeptidases that cleave Kinins into active kinin metabolites (des-Arg9-
Bradykinin/ des-Arg10-Kallidin).
2. *Angiotensin I-Converting Enzyme (ACE) (also known as Kininase II)
hydrolyzes Bradykinin into inactive products. The cardioprotective and blood
pressure lowering effects of ACE inhibitors (like Captopril) may in part be
due to increases in Bradykinin.
Kinin Receptors
1.B1 and B2 are G protein coupled receptors
2. Native Bradykinin and kallidin activate the B2 receptor.
3. Bradykinin and kinin active metabolites (des-Arg9
-Bradykinin/ des-Arg10-
Kallidin) activate the B1 receptor
4. B2 receptor constitutively expressed in most tissues
5. B1 receptor is induced by tissue damage, inflammation
6. Activation of B receptors stimulates increases in the synthesis of
prostaglandins, NO, EDHF
Drug interactions of Kinins
1.NSAIDS reduce bradykinin and Kallidin-induced increases in PG production
by inhibiting cyclo-oxygenase
2. Corticosteroids reduce bradykinin and Kallidin-induced PG production by
stimulating increases in Lipocortin. Lipocortin is a phospholipase A2
inhibitor
Effects of kinins
1.Pain: kinins can induce the excitation of sensory neurons, which induces the
release of neuropeptides, substance P, neurokinins, and calcitonin gene related
peptide (CGRP). *CGRP is the most potent vasodilator peptide in the
trigeminal system (important for Migraine).
2.Inflammation: Kinins increase permeability of microcirculation which can
promote edema
3. Respiration: Kinins can induce bronchospasms and kinin levels can be
elevated in asthma
4. Cardiovascular: Kinins induce vasodilation and lower BP
Serotonin (5-HT): Biological effects. Platelets, cardiovascular, GI, and CNS
1.Platelets
a) Platelets do not synthesize serotonin but actively take up and store
serotonin. Serotonin release during platelet aggregation promotes platelet
aggregation and vasoconstriction.
2.Cardiovascular
a) Induces vasoconstriction and has positive inotropic and chronotropic
effects on heart
3.GI
a) Enterochromaffin cells release 5-HT in response to vagal stimulation and
stretching with food ingestion. 5-HT will regulate GI motility. 5-HT
producing carcinomas will induce diarrhea and abdominal cramps.
4.CNS
a) 5-HT neurons in raphe nuclei of brain stem and project throughout the
brain and spinal cord.
Synthesis and inactivation of 5-HT
- Serotonin is preferentially inactivated by monoamine oxidase A (MAO-A)
isoform, platelets only express the MAO-B isoform - 5-Hydroxyindoleacetic acid (5-HIAA) is the urinary metabolite of 5-HT
*5-HT1 Receptors
- There are seven 5-HT receptor subtypes some of which have defined
functions including the 5-HT1 family. - The role of 5-HT1B/1D receptors in migraine
a) *5-HT1D induce vasoconstriction of cranial blood vessels. *5-HT1B is an
autoreceptor and its activation inhibits nociceptive trigeminal afferents,
which reduces migraine pain.
Role of 5-HT in Migraine
- Urinary and platelet 5-HT levels decrease during Migraine attacks
- *Triptans are 5-HT1B/1D agonist to treat migraine pain.
- Intravenous infusion of 5-HT aborts spontaneous headache
Migraine Headaches overview and types
1.Afflict over 23 million individuals each year.
Common migraine: Has no aura and has headache.
Classic Migraines: Have aura and HA
Aura
Sensory disturbance in brain prior to headache
• Visual disturbance → scintillating scotoma
• Sensory disturbance → Focal paresthesia
• Motor disturbance → Weakness or paralysis
• Auditory Disturbance → Excessively sensitive to noise or light
Migraine stages
a) Prodome (1 – 2 days prior to attack) GI effects Mood changes
b) Aura (20- 60 min prior to attack)
c) Attack 4hrs – 3 days
d) Postdrome